How closely related is graft-vs-leukemia to donor/recipient disparity?

被引：6
|
作者：
Weisdorf, Daniel J. [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN 55455 USA
来源：
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2010年 / 23卷 / 04期
关键词：
graft-vs-leukemia effect; GVL; graft-vs-host disease; GVHD; acute leukemia; human leukocyte antigen; HLA; mismatch; unrelated donor; cord blood; conditioning regimen; VERSUS-HOST-DISEASE; CELL TRANSPLANTATION; SEVERITY; RELAPSE; DONORS;
D O I：
10.1016/j.beha.2010.09.015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Graft-vs-host disease (GVHD) is an unwanted complication of stem cell transplant, but the graft-vs-leukemia (GVL) effect has been shown to positively affect outcomes. GVHD and GVL have similar but not identical alloreactivity, and GVL may be affected by the source of grafts, the preparative conditioning regimen, and donor genetic elements. Human leukocyte antigen (HLA) mismatch does not appear to augment the GVL effect, and increased GVHD does not necessarily lead to decreased relapse. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：525 / 528
页数：4
相关论文
共 50 条
  • [1] Induction of graft-vs-leukemia as a therapeutic modality
    Champlin, R
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 723 - 723
  • [2] GRAFT-VS-LEUKEMIA IN MAN - A PRELIMINARY-REPORT
    BUTTURINI, A
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 475 - 475
  • [3] GRAFT-VS-LEUKEMIA AND MODERATION OF GRAFT-VS-HOST REACTION IN TRANSPLANTATION THERAPY OF VIRAL LEUKEMIA
    OKUNEWICK, JP
    MEREDITH, RF
    RAIKOW, RB
    BROZOVICH, BJ
    MAGLIERE, K
    EXPERIMENTAL HEMATOLOGY, 1981, 9 (07) : 754 - 765
  • [4] SEPARATION OF GRAFT-VS-HOST DISEASE AND GRAFT-VS-LEUKEMIA EFFECT AGAINST CHRONIC MYELOGENOUS LEUKEMIA
    CHAMPLIN, R
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (11) : 1148 - 1151
  • [5] CORRELATION OF GRAFT-VS-HOST AND GRAFT-VS-LEUKEMIA REACTIVITY IN ALLOGENEIC MARROW TRANSPLANTATION THERAPY OF MURINE VIRAL LEUKEMIA
    OKUNEWICK, JP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 31 - 31
  • [6] Induction of graft-vs-leukemia (GVL) as primary treatment of chronic myelogenous leukemia (CML).
    Giralt, S
    Gajewski, J
    Khouri, I
    Korbling, M
    Claxton, D
    Mehra, R
    Przepiorka, D
    Andersson, B
    Talpaz, M
    Kantarjian, H
    Champlin, R
    BLOOD, 1997, 90 (10) : 1857 - 1857
  • [7] Graft-vs-leukemia in a retrovirally induced murine CML model: Mechanisms of leukemia recognition.
    Shlomchik, W
    Pear, WS
    BLOOD, 2001, 98 (11) : 812A - 812A
  • [8] THE ROLE OF A GRAFT-VS-LEUKEMIA REACTION (GVLR) IN THE TREATMENT OF LEUKEMIA WITH BONE-MARROW TRANSPLANTATION (BMT)
    KLOOSTERMAN, TC
    TIELEMANS, MJC
    GAISER, JF
    MARTENS, ACM
    HOOGERBRUGGE, PM
    VANBEKKUM, DW
    HAGENBEEK, A
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 580 - 580
  • [9] THE GRAFT-VS-LEUKEMIA EFFECT - IMPLICATIONS FOR POST-MARROW TRANSPLANT ANTILEUKEMIA TREATMENT
    SOSMAN, JA
    SONDEL, PM
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1993, 15 (02): : 185 - 195
  • [10] EVIDENCE FOR POSSIBLE INVOLVEMENT OF ASIALO-GM1+ CELLS IN GRAFT-VS-LEUKEMIA
    OKUNEWICK, J
    KOCIBAN, D
    MACHEN, L
    BUFFO, M
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 727 - 727
12345